Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Enlivex Therapeutics Ltd
(NQ:
ENLV
)
1.670
+0.010 (+0.60%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 30, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
106,682
Open
1.650
Bid (Size)
1.670 (1)
Ask (Size)
1.720 (1)
Prev. Close
1.660
Today's Range
1.600 - 1.700
52wk Range
1.150 - 4.590
Shares Outstanding
18,306,186
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Why Clever Leaves Holdings Shares Are Trading Lower By Around 60%? Here Are Other Stocks Moving In Monday's Mid-Day Session
April 29, 2024
Via
Benzinga
Enlivex CEO Issues Letter to Shareholders – Perspectives on Recent Events
April 29, 2024
From
Enlivex Therapeutics Ltd
Via
GlobeNewswire
Performance
YTD
-49.39%
-49.39%
1 Month
-58.25%
-58.25%
3 Month
-39.05%
-39.05%
6 Month
+25.56%
+25.56%
1 Year
-40.78%
-40.78%
More News
Read More
Enlivex Announces Dosing of First Two Patients in its Randomized, Controlled Phase I/II Trial Evaluating Allocetra™ in Patients with Knee Osteoarthritis
April 22, 2024
From
Enlivex Therapeutics Ltd
Via
GlobeNewswire
Enlivex Announces Authorization from the Danish Regulatory Agency for the Company’s Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Patients with Knee Osteoarthritis
April 16, 2024
From
Enlivex Therapeutics Ltd
Via
GlobeNewswire
Tesla To $180? Here Are 10 Top Analyst Forecasts For Friday
April 12, 2024
Via
Benzinga
Nasdaq Jumps 250 Points; Crude Oil Down 1%
April 11, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Enlivex to Host Webcast on April 12, 2024 at 8:30 a.m. Eastern Time to Discuss Topline Results from Its Phase II Trial Evaluating Allocetra™ In Patients with Sepsis
April 11, 2024
From
Enlivex Therapeutics Ltd
Via
GlobeNewswire
Why Fastenal Shares Are Trading Lower By Around 7%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
April 11, 2024
Via
Benzinga
Dow Dips 100 Points; CarMax Earnings Miss Views
April 11, 2024
Via
Benzinga
Topics
Earnings
Stocks
Exposures
Financial
US Equities
Nasdaq Gains Over 50 Points; US Producer Prices Increase In March
April 11, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Enlivex Announces Topline Results of Its Phase II Trial Evaluating Allocetra™ In Patients With Sepsis
April 11, 2024
From
Enlivex Therapeutics Ltd
Via
GlobeNewswire
ENLV Stock Earnings: Enlivex Therapeutics Misses EPS for Q4 2023
April 05, 2024
Via
InvestorPlace
Enlivex Therapeutics and Unusual Machines Interviews to Air on the RedChip Small Stocks, Big Money(TM) Show on Bloomberg TV
March 22, 2024
Via
ACCESSWIRE
Enlivex Receives Regulatory Authorization From Israel’s Health Ministry For The Initiation Of Phase 1/2 Trial Evaluating Allocetra In Patients With Knee Osteoarthritis
February 26, 2024
Via
ACCESSWIRE
Enlivex Completes Enrollment Of All 120 Patients In Phase 2 Trial Of Allocetra In Patients With Sepsis, Third-Leading Cause Of Mortality In US Hospitals
February 21, 2024
Via
ACCESSWIRE
Enlivex Announces Issuance of New U.S. Patent Covering Allocetra Cells and Their Manufacturing Method
February 07, 2024
From
Enlivex Therapeutics Ltd
Via
GlobeNewswire
Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis
January 17, 2024
From
Enlivex Therapeutics Ltd
Via
GlobeNewswire
Enlivex Therapeutics Ltd. (NASDAQ: ENLV) Leading the Way in Tuesday Trading Based on Percentage Gain
January 02, 2024
Via
Investor Brand Network
Exposures
COVID-19
Why RayzeBio Shares Are Trading Higher By 100%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
December 26, 2023
Via
Benzinga
Enlivex Announces Completion of Enrollment of Its Phase II Trial Evaluating Allocetra In Patients With Sepsis
December 20, 2023
From
Enlivex Therapeutics Ltd
Via
GlobeNewswire
Why AAR Shares Are Trading Lower By 7%? Here Are Other Stocks Moving In Friday's Mid-Day Session
December 22, 2023
Via
Benzinga
MediWound Announces Appointment of Shmulik Hess, Ph.D. as Chief Operating Officer and Chief Commercial Officer
November 21, 2023
From
MediWound Ltd.
Via
GlobeNewswire
Why Fortinet Shares Are Trading Lower By Around 17%? Here Are Other Stocks Moving In Friday's Mid-Day Session
November 03, 2023
Via
Benzinga
Enlivex Announces Reprioritization Plan and Second Quarter 2023 Financial Results
September 11, 2023
From
Enlivex Therapeutics Ltd
Via
GlobeNewswire
Enlivex to Present at the H.C. Wainwright 25th Annual Global Investment Conference
September 07, 2023
From
Enlivex Therapeutics Ltd
Via
GlobeNewswire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.